- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01572506
Mechanisms Accounting for Unexplained Anemia in the Elderly
Assessing Mechanisms Accounting for Unexplained Anemia in the Elderly
Background:
- Anemia occurs commonly and is associated with poor outcomes in the elderly. In about a third of anemia cases in older people (over age 65), the cause of anemia is unexplained. Anemia in older adults may be caused by the bone marrow's inability to produce red blood cells fast enough to replace older red blood cells that have died. Researchers want to look at unexplained anemia by studying the life span of red blood cells in younger adults and older adults. To do so, a vitamin called Biotin will be used as a marker on the red blood cells.
Objectives:
- To investigate possible causes of unexplained anemia in older people.
Eligibility:
- Individuals in the following groups:
- Men and women between 18 and 50 years of age who do not have anemia
- Men and women at least 70 years of age who do not have anemia.
- Men and women at least 70 years of age who have iron-deficiency anemia.
- Men and women at least 70 years of age who have anemia with no known cause.
Design:
- Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected.
- Participants will have an overnight stay for the first study visit. They will provide a blood sample to which Biotin will be added. The blood sample with Biotin will then be returned to the participant. Twenty-four hours later, another blood sample will be collected.
- Participants will have up to 14 additional study visits. At each visit, blood samples will be collected to measure the amount of Biotin remaining in the blood.
- Participants may also provide a separate blood sample for genetic testing. These tests may provide more information about genetic causes of unexplained anemia.
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21224
- National Institute of Aging, Clinical Research Unit
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
- INCLUSION CRITERIA:
- Ambulatory, community dweller
- Age greater than or equal to 70 years or older or between the ages of 18 and 50 years.
- Able to understand English
- Able to complete study questionnaires as determined by the investigator
- Evidence for recent (within 1 year) clinical evaluation for blood loss directed by primary care physician or consultant in subjects referred with microcytic anemia or with referring laboratories indicative of iron deficiency. Furthermore, subjects found to have microcytic anemia will be eligible but will be referred to their primary doctor for evaluation of blood loss.
- Provide informed consent
EXCLUSION CRITERIA:
- Hemoglobin (Hb) less than 9 g/dL during screening
- History of red blood cell transfusion withinthe 3 month period prior to accrual to this study, or evidence for active bleeding as ascertained by medical history (e.g., persistent melena, hematuria or dysfunctional uterine bleeding).
- Patients for whom oral iron supplementation has been prescribed within the past two months. (Patients on a stable dose of oral iron for more than two months may be eligible).
- ALT or AST more than 3 times upper normal limitation of the time of screening
- B12 or folate deficiencies during screening period
- Estimated GFR less than 30 ml/min/1.73m(2)during screening period (by the 4-variable Modification of Diet in Renal Disease [MDRD] equation).
- Receiving hemodialysis or peritoneal dialysis for renal failure, or history of kidney transplant
- Use of exogenous erythropoietin during the past 3 months
- Any major surgery requiring general anesthesia within the past 3 months
- Treatment with chemotherapy or radiotherapy in the past 12 months
- Current diagnosis of active cancer, other than non-melanoma skin cancer and, stable prostate cancer
- History of blood disorders including thalassemia, sickle cell disease or myelodysplasia
- Current severe (NYHA Class III - IV) congestive heart failure or advanced chronic obstructive pulmonary disease
- Positive serum monoclonal protein and immunofixation
- Women who are pregnant or women planning to get pregnant during the duration of the study or those with a positive pregnancy test during screening
- Active infection requiring antibiotic treatment or HIV, Hepatitis B or C
- History of overt chronic inflammation, active Crohn s disease, rheumatoid arthritis, or diabetes(HbA1C greater than 7),
- Known hemolytic anemia
- History of prosthetic heart valve
- History of participation in biotinylation studies or handling biotinylated reagent products.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group 1
Age 70 and older with unexplained anemia
|
|
Active Comparator: Group 2
Age 70 and older with iron deficient anemia
|
|
Active Comparator: Group 3
Age 70 and older without anemia
|
|
Active Comparator: Group 4
Age 18 - 50 without anemia
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
---|---|
Measurement of red blood cell survival
|
Directly measure red blood cell survival and to correlate this with aspects of red blood cell physiology that may increase susceptibilty to the hemolytic process
|
Collaborators and Investigators
Investigators
- Principal Investigator: Josephine M Egan, M.D., National Institute on Aging (NIA)
Publications and helpful links
General Publications
- Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004 Oct 15;104(8):2263-8. doi: 10.1182/blood-2004-05-1812. Epub 2004 Jul 6.
- Ershler WB, Sheng S, McKelvey J, Artz AS, Denduluri N, Tecson J, Taub DD, Brant LJ, Ferrucci L, Longo DL. Serum erythropoietin and aging: a longitudinal analysis. J Am Geriatr Soc. 2005 Aug;53(8):1360-5. doi: 10.1111/j.1532-5415.2005.53416.x.
- Artz AS, Fergusson D, Drinka PJ, Gerald M, Gravenstein S, Lechich A, Silverstone F, Finnigan S, Janowski MC, McCamish MA, Ershler WB. Prevalence of anemia in skilled-nursing home residents. Arch Gerontol Geriatr. 2004 Nov-Dec;39(3):201-6. doi: 10.1016/j.archger.2004.03.006.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 999912109
- 12-AG-N109
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anemia
-
SanofiActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)United States, Austria, China, Denmark, Germany, Hungary, Italy, Spain, United Kingdom
-
SanofiTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)United Kingdom, Belgium, Netherlands, France, United States, Germany, Hungary, Italy
-
Hospital Universitario Dr. Jose E. GonzalezCompletedPernicious Anemia | Megaloblastic Anemia NosMexico
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSevere Aplastic Anemia | Idiopathic Aplastic Anemia | Moderate Aplastic Anemia Requiring Transfusions
-
Abdelwahed, Mai Mahmoud Mohamed, M.D.UnknownAnemia During PregnancyEgypt
-
University of California, DavisInstituto Mexicano del Seguro Social; Thrasher Research Fund; Mexican National... and other collaboratorsCompleted
-
Incyte CorporationActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)Spain, United States, Austria, Belgium, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Poland, United Kingdom
-
Cornell UniversityUniversity of California, Los AngelesCompletedPregnancy Anemia | Newborn; AnemiaUnited States
-
Peking Union Medical College HospitalRecruiting
Clinical Trials on Biotin RBC survival
-
Fondazione Policlinico Universitario Agostino Gemelli...Fresenius HemocareRecruitingRetinopathy of PrematurityItaly
-
Daping Hospital and the Research Institute of Surgery...Children's Hospital of Chongqing Medical UniversityWithdrawnAnemia | Necrotizing Enterocolitis | Red Blood Cell (RBC) TransfusionChina
-
The Cleveland ClinicCompletedCardiac Surgery | Blood TransfusionUnited States
-
German Resuscitation RegistryCompletedCardiac Arrest
-
Mayo ClinicCompletedBlood Protein Disorders | Pulmonary EdemasUnited States
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Canadian Blood ServicesActive, not recruitingRed Blood Cell TransfusionCanada
-
University of MiamiNational Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Artery BypassUnited States
-
University of EdinburghNHS Lothian; Chief Scientist Office of the Scottish Government; Transfusion Medicine...CompletedAnemia | Blood Transfusion | Intensive CareUnited Kingdom
-
Carnegie Mellon UniversityCompleted
-
Oregon Health and Science UniversityUnited States Air Force; Armed Services Blood ProgramCompleted